| FIELD OF APPLICATION | DETAILS |
|---|---|
| Generic Name | Octamoxin |
| Active Ingredient | Octamoxin |
| Drug Category | Psychiatry |
| Drug Class | Palliative treatment, Immunosuppressive therapy, Targeted therapy |
| Brand Names | Nimaol, Ximaol |
| Dosage Forms | Oral Tablets |
| Route of Administration | Oral |
| FDA Approval Status | Not approved |
Pheniprazine Overview
Pheniprazine is a historical psychotropic medication that was previously utilized within the Psychiatry department for the management of severe clinical depression, schizophrenia, and angina pectoris. Chemically, this compound belongs to the class of organic compounds known as amphetamines and derivatives, which are organic compounds containing or derived from 1-phenylpropan-2-amine. Functioning biologically as an irreversible and nonselective monoamine oxidase inhibitor (MAOI) of the hydrazine chemical class, Pheniprazine was heavily employed in the 1960s. However, its clinical lifespan was relatively brief. The drug was ultimately withdrawn by its manufacturer due to its significant potential to cause profound toxicity in the liver and its direct association with optic neuritis.
What Is Pheniprazine & How Does It Work?
Pheniprazine is a small molecule psychoanaleptic that functions biologically as an irreversible monoamine oxidase inhibitor (MAOI). It acts as a potent inhibitor and inactivator of both Amine oxidase [flavin-containing] A (MAO-A) and Amine oxidase [flavin-containing] B (MAO-B). By permanently binding to and inactivating these essential monoamine oxidase enzymes in the central nervous system, Pheniprazine prevented the metabolic breakdown of vital biogenic amines, including serotonin, norepinephrine, and dopamine.
This profound enzymatic blockade resulted in a massive accumulation of these neurotransmitters within the synaptic cleft. The resulting enhancement of neural signaling elevated mood and alleviated the pervasive symptoms of severe depressive disorders. Furthermore, its unique amphetamine-derived structure contributed to its temporary use in other complex conditions like schizophrenia and angina pectoris before its severe toxicity profile was fully realized.
Is Pheniprazine FDA Approved?
Pheniprazine is not approved by the United States Food and Drug Administration (FDA) for clinical prescription in the United States. Although it was utilized internationally as an antidepressant in the 1960s under brand names such as Catron and Cavodil, it was ultimately withdrawn from all global markets by its manufacturer. Because of its documented ability to cause severe liver toxicity and optic nerve damage, it remains an unapproved and discontinued therapeutic agent.
What Is Pheniprazine Used For?
- The historical symptomatic treatment and clinical management of severe clinical depression.
- Utilized historically for the management of schizophrenia symptoms before safer and more targeted antipsychotics were developed.
- Historically prescribed for the treatment of angina pectoris (severe chest pain) due to its cardiovascular effects as an MAOI.
- Currently, it serves no approved clinical purpose and is exclusively a compound of historical and toxicological interest.
Before Taking Pheniprazine: Contraindications & Precautions
Because Pheniprazine is an irreversible MAOI that carries a documented risk of fatal liver damage and optic neuritis, extreme clinical caution, stringent dietary restrictions, and extensive drug screening were absolute requirements during its time of use. Today, its administration is universally contraindicated.
Who Should Not Take Pheniprazine?
- Patients with any pre-existing hepatic impairment, active liver disease, or elevated liver enzymes, as the drug is a known cause of severe liver toxicity.
- Individuals with a history of vision problems or optic nerve disease, due to its documented ability to cause optic neuritis.
- Patients with a history of cardiovascular disease, uncontrolled hypertension, or cerebrovascular defects, due to the standard MAOI risk of severe hypertensive crises.
- Patients currently taking other serotonergic drugs, central nervous system depressants, or sympathomimetic agents.
Pheniprazine: Pregnancy & Fertility
- The safety of Pheniprazine during human pregnancy was never established through modern, controlled clinical trials.
- Pregnant women were historically advised against using MAOIs unless absolutely necessary, as these agents can cause severe maternal hypertensive crises and severely compromise fetal blood flow.
- Nursing mothers were historically cautioned against its use, as toxic psychoactive compounds and MAOIs can be excreted into human breast milk, posing extreme risks to the nursing infant.
Tell Your Doctor Before Taking Pheniprazine
- Disclose any personal or family history of liver disease, hepatitis, or abnormal liver function tests.
- Inform your doctor if you consume high amounts of tyramine-rich foods, as this is strictly contraindicated with any MAOI therapy.
- List all other medications, specifically highlighting other antidepressants, cold medicines, or weight-loss supplements, to avoid severe, lethal drug-to-drug interactions.
Pheniprazine: Dosage & Administration
As an unapproved and discontinued medication that is no longer marketed anywhere in the world, standardized domestic dosing guidelines, specific dosage forms, and routes of administration for Pheniprazine are currently listed as not available in modern pharmacological databases.
Standard Pheniprazine Dosing
- When it was prescribed historically, dosing for hydrazine MAOIs like Pheniprazine was highly individualized and required careful titration by a specialized psychiatrist to balance antidepressant efficacy against autonomic, visual, and hepatic side effects.
- In modern medicine, it is not prescribed in standard clinical practice, and its therapeutic dosing regimens are entirely obsolete.
How Pheniprazine Is Administered
- Specific formulation and route details are not currently available for Pheniprazine, though historical MAOIs of this era were universally administered as oral tablets or capsules.
Pheniprazine: Clinical Efficacy & Research
During its brief period of clinical employment in the 1960s, Pheniprazine proved to be an effective psychoanaleptic. By acting as an irreversible MAOI, it successfully elevated monoamine neurotransmitter levels to combat severe depressive symptoms, and it showed some clinical utility in treating schizophrenia and angina pectoris. However, its clinical efficacy was rapidly overshadowed by its catastrophic safety profile. Pharmacovigilance efforts quickly identified that Pheniprazine caused severe toxicity in the liver and triggered optic neuritis, leading to severe vision changes. Consequently, the drug was voluntarily withdrawn by its manufacturer, leading to its permanent discontinuation.
Pheniprazine: Side Effects & Safety Profile
Octamoxin does not carry an FDA Black Box Warning. It has never been approved for clinical prescription or commercial distribution in the United States by the US Food and Drug Administration.
The safety profile of Pheniprazine is dominated by the severe, life-threatening risks associated with acute hepatic failure, optic nerve damage, and irreversible monoamine oxidase inhibition.
Common Pheniprazine Side Effects
- Orthostatic hypotension (severe dizziness or lightheadedness upon standing up quickly).
- Anticholinergic-like effects, such as a persistently dry mouth, blurred vision, and mild to moderate constipation.
- Central nervous system depression resulting in daytime drowsiness, fatigue, or generalized lethargy.
Serious Pheniprazine Adverse Events
- Severe liver toxicity and drug-induced liver injury, potentially leading to acute liver failure and jaundice.
- Optic neuritis, an inflammation of the optic nerve that can cause severe eye pain and permanent vision loss.
- Severe, potentially fatal hypertensive crises, especially if the drug is consumed concurrently with tyramine-rich foods.
- Serotonin syndrome, characterized by severe agitation, hallucinations, hyperthermia (extreme fever), and a rapid, irregular heart rate.
Managing Pheniprazine Side Effects
If signs of acute liver injury occurred such as sudden yellowing of the skin or eyes (jaundice) or dark urine the drug was immediately discontinued. Similarly, if patients reported sudden vision changes, blurry vision, or eye pain, treatment was halted to prevent permanent blindness. If signs of a hypertensive crisis or serotonin syndrome emerged, immediate hospitalization was required for intensive cardiovascular and neurological supportive care.
Pheniprazine: Interactions & What to Avoid
Pheniprazine interacted profoundly and dangerously with a vast array of medications and dietary components, particularly those affecting serotonin pathways, vascular tone, and hepatic metabolism.
Pheniprazine: Interactions
- Co-administration with other serotonergic drugs (like SSRIs, SNRIs, tricyclics, or other MAOIs) significantly increases the risk of life-threatening Serotonin Syndrome.
- Combining Pheniprazine with central nervous system depressants can cause severe, additive respiratory and cognitive depression.
- Concomitant use with sympathomimetic agents (such as pseudoephedrine found in over-the-counter cold medicines) can trigger uncontrollable, lethal spikes in blood pressure.
Pheniprazine: Food & Alcohol
- Strict dietary restrictions are an absolute requirement for MAOIs like Pheniprazine. Patients must completely avoid tyramine-rich foods (such as aged cheeses, cured meats, fermented soy products, and tap beer) to prevent fatal hypertensive crises.
- Alcohol consumption must be strictly avoided. Many alcoholic beverages contain high levels of tyramine, and alcohol itself dangerously amplifies the central nervous system depression and hepatic strain associated with the drug.
Pheniprazine: Missed Dose, Overdose & Storage
Because the drug is no longer used in standard clinical practice, daily patient dosing schedules do not currently apply.
Missed Dose of Pheniprazine
Historically, if a dose of Pheniprazine was missed, patients were advised to take it as soon as remembered unless it was nearly time for the next scheduled dose. They were strictly warned to avoid taking double doses to prevent sudden, overwhelming hepatic toxicity or autonomic crises.
Pheniprazine: Overdose & Emergency
An overdose of a hydrazine MAOI like Pheniprazine is a catastrophic medical emergency. Symptoms of toxicity rapidly progress to profound central nervous system depression, extreme tachycardia, hyperpyrexia (severe, dangerous fever), continuous convulsions, coma, and acute liver failure. Emergency medical treatment focuses on immediate intensive cardiovascular monitoring, gastric decontamination, and robust supportive care to manage hyperthermia, seizures, and organ failure.
How to Store Pheniprazine
If retained for toxicological or historical research, Pheniprazine compounds must be stored in highly controlled laboratory environments at room temperature, protected from excessive light and moisture, and kept strictly out of the reach of unauthorized personnel.
Pheniprazine: Patient Management & Monitoring
When it was used clinically, psychiatric treatment with an irreversible MAOI required extreme vigilance regarding liver health, vision, and dietary compliance.
Tests Before Starting Pheniprazine
- Comprehensive baseline liver function tests (LFTs) to completely rule out pre-existing hepatic impairment.
- A baseline ophthalmic examination to evaluate optic nerve health and visual acuity.
- A baseline cardiovascular evaluation, checking resting blood pressure to rule out severe hypertension.
Monitoring During Pheniprazine Treatment
- Routine, strict monitoring of liver enzymes (ALT, AST, bilirubin) during clinical visits to detect any early signs of drug-induced liver toxicity.
- Frequent eye exams to closely monitor for the development of optic neuritis.
- Continuous psychiatric evaluation to assess the reduction of depressive or schizophrenic symptoms and ensure total adherence to MAOI dietary restrictions.
Pheniprazine: Do’s and Don’ts
- Do strictly adhere to a low-tyramine diet if you are ever exposed to an MAOI in a medical setting.
- Do not attempt to source or use Pheniprazine for personal psychiatric treatment, as it is an unapproved, unmarketed, and highly toxic medication.
- Do not consume alcohol, aged cheeses, or cured meats while undergoing any form of MAOI therapy.
- Do not mix this compound with other antidepressants, asthma inhalers, or over-the-counter cold and allergy medicines.
Frequently Asked Questions
What was Pheniprazine primarily used for?
Historically, Pheniprazine was employed as an antidepressant in the 1960s. It was also utilized in the management of schizophrenia and angina pectoris before it was globally discontinued.
How did Pheniprazine affect the brain?
It functioned as an irreversible monoamine oxidase inhibitor (MAOI). It permanently blocked the enzymes (MAO-A and MAO-B) responsible for breaking down neurotransmitters like serotonin, dopamine, and norepinephrine, allowing them to accumulate in the brain.
Is Pheniprazine approved for use in the United States?
No, Pheniprazine is not approved by the US FDA for prescription use and remains an unapproved, unmarketed, and discontinued therapeutic agent.
Why was Pheniprazine withdrawn by its manufacturer?
Pheniprazine was withdrawn by its manufacturer because it demonstrated a high potential to cause severe toxicity in the liver and was shown to cause optic neuritis (inflammation of the optic nerve), which could lead to permanent vision loss.
What are the most serious side effects of Pheniprazine?
The most serious risks involve fatal acute liver failure, optic neuritis leading to blindness, life-threatening hypertensive crises (especially when combined with tyramine-rich foods), and severe Serotonin Syndrome.
Can Pheniprazine be prescribed today?
No, it is no longer actively marketed or prescribed for clinical medical use anywhere in the world due to its severe toxicity profile.
References
- DrugBank Database – Pheniprazine Clinical and Pharmacological Profile
- Classyfire Database – Amphetamines and Derivatives Chemical Taxonomy Profile
Legal Disclaimer
The information provided is for educational and informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider at any hospital or any local clinic before starting or stopping any medication.

























